首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷拋棄式內視鏡檢查設備

市場調查報告書

商品編碼

1776208

拋棄式內視鏡的全球市場 - 市場考察，競爭情形，市場預測(2032年)

Disposable Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日期: 2025年07月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球一次性內視鏡市場預計將從 2024 年的 26.5844 億美元成長至 2032 年的 57.4875 億美元，2025 年至 2032 年的複合年增長率為 10.19%。醫療保健環境中交叉污染和感染的增加推動了對更安全替代品的需求，例如無需再處理並可降低感染風險的一次性內視鏡。此外，胃腸道、呼吸道和泌尿道等慢性疾病的發生率上升，也推動了用於診斷和治療的內視鏡手術數量的增加。此外，持續的產品開發，包括成像、便攜性和人工智慧整合方面的進步，正在提高設備的性能和易用性。這些因素將顯著推動2025年至2032年全球一次性內視鏡市場的整體成長。

一次內視鏡市場動態

根據世界衛生組織 (WHO) (2022) 的數據，每100名入住急診醫院的患者中，高收入國家約有7名，中低收入國家約有15名在住院期間至少發生一次醫院相關感染 (HAI)。此外，報告估計，全球每年約有1.36億例抗生素抗藥性醫院相關感染。

儘管可重複使用的內視鏡經過再處理，但仍對傳播傳染病構成重大風險，包括抗藥性細菌，如艱難梭菌、綠膿桿菌、抗甲氧西林金黃色葡萄球菌 (MRSA)、萬古黴素腸球菌 (VRE) 和抗藥性腸球菌 (CRE)。相較之下，一次性內視鏡是一種無菌的一次性解決方案，消除了消毒失敗的風險。因此，它們特別適用於重症監護病房 (ICU) 和急診室等高風險環境。因此，對改善感染控制和更安全、更有效率的臨床實踐的需求正在推動對一次性內視鏡的需求不斷增長。

此外，呼吸系統、胃腸道和泌尿系統疾病的盛行率不斷上升，進一步推動了一次性內視鏡市場的發展。根據世界胃腸病學組織 (2023) 的數據，全球約有 49% 的女性和 36.6% 的男性符合至少一種功能性胃腸道疾病的診斷標準。同樣，根據泌尿外科基金會 (2023) 的數據，英國約有一半的人患有泌尿系統疾病。這種盛行率的上升促使對診斷和治療程序的需求增加，從而推動了對一次性內視鏡解決方案的需求。

可重複使用內視鏡雖然有效，但它們需要複雜、耗時且昂貴的再處理方案，並且存在交叉污染的風險。隨著門診手術中心和急診內視鏡手術的增多，一次性內視鏡提供了一種實用的替代方案。一次性內視鏡可降低感染風險，縮短手術時間，並提高病患吞吐量。

此外，主要產業參與者正在進行的產品開發活動也支持了市場擴張。例如，2022年5月，Ambu的無菌拋棄式支氣管鏡產品Ambu® aScope™ 5 Broncho獲得了歐洲監管機構的批准。

因此，預計上述因素將在2025-2032預測期內共同推動一次性內視鏡市場的成長。

然而，儘管存在這些優勢，但某些限制可能會阻礙市場成長。一次性內視鏡作為一次性使用設備，會產生醫療廢棄物，引發環境和永續性的擔憂。此外，由於其不適用於複雜的手術，可能會限制其在某些臨床環境中的應用，從而嚴重限制其更廣泛的市場擴張。

預計北美將主導整個一次性內視鏡市場

預計到2024年，北美將引領全球一次性內視鏡市場，原因包括醫療相關感染 (HAI) 發病率上升、泌尿系統和胃腸道疾病等慢性疾病盛行率上升以及醫療技術的持續進步。

本報告對全球一次性內視鏡市場進行了研究和分析，提供了市場規模和預測、過去三年產品/服務發展、主要市場參與者以及可用機會等資訊。

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing instances of cross-contamination and infections, increasing prevalence of chronic conditions, and rising product developmental activities globally.

The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032. The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

Disposable Endoscopes Market Dynamics:

According to data from the World Health Organization (2022), for every 100 patients admitted to acute-care hospitals, approximately 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay. Furthermore, the same report estimates that around 136 million cases of healthcare-associated, antibiotic-resistant infections occur globally each year.

Reusable endoscopes, despite undergoing reprocessing, continue to pose a significant risk of transmitting infections such as Clostridioides difficile, Pseudomonas aeruginosa, and drug-resistant organisms like MRSA, VRE, and CRE. In contrast, disposable endoscopes offer a sterile, single-use solution that eliminates the risk of disinfection failures. This makes them particularly suitable for high-risk environments such as intensive care units (ICUs) and emergency departments. Consequently, the need for improved infection control and safer, more efficient clinical practices is fueling the growing demand for disposable endoscopes.

In addition, the increasing prevalence of respiratory, gastrointestinal, and urological conditions is further driving the disposable endoscope market. According to the World Gastroenterology Organization (2023), approximately 49% of females and 36.6% of males globally meet the criteria for at least one functional gastrointestinal disorder. Similarly, data from the Urology Foundation (2023) indicate that around one in two individuals in the United Kingdom experiences a urological condition. These rising disease rates are contributing to increased demand for diagnostic and therapeutic procedures, thereby boosting the need for disposable endoscopic solutions.

While reusable endoscopes are effective, they require complex, time-consuming, and costly reprocessing protocols, which also carry a risk of cross-contamination. With a growing number of endoscopic procedures being performed in outpatient settings, ambulatory surgical centers, and emergency departments, disposable endoscopes offer a practical alternative. They reduce infection risk, shorten turnaround times, and enhance patient throughput.

Moreover, ongoing product development efforts by key industry players are supporting market expansion. For example, in May 2022, Ambu received European regulatory approval for its Ambu(R) aScope(TM) 5 Broncho, a line of sterile, single-use bronchoscopes.

Therefore, the factors outlined above are expected to collectively drive the growth of the disposable endoscopes market during the forecast period from 2025 to 2032.

However, despite these advantages, certain limitations could hinder market growth. As single-use devices, disposable endoscopes contribute to medical waste, raising environmental and sustainability concerns. Additionally, their limited suitability for complex procedures may restrict adoption in some clinical settings, serving as key constraints on broader market expansion.

Disposable Endoscopes Market Segment Analysis:

In the products segment of disposable endoscopes, the bronchoscopes category is expected to have a significant revenue share in the year 2024. This can be ascribed to their advantages, such as the use of bronchoscopes in the diagnosis and treatment of tumors and bronchial cancers, airway blockage (obstruction), narrowed areas in the airways, and interstitial pulmonary diseases, among others.

Another key aspect contributing in the growing demand for bronchoscopes is that it also comprises of increased detection and improved access, reaching to the most distant regions of the lungs, earlier diagnosis of lung tumors, better treatment decisions, reduced risk associated with complications, and eliminating the risk associated with invasive surgeries, all of the advantages possible due to the presence of navigational bronchoscopy.

Given the advantages associated with navigational bronchoscopy, there has been increasing acceptance among end users, which in turn has led to a rise in the number of new product launches in the market. For example, in April 2023, Verathon, a leading global medical device company, announced the launch of the BFlex(TM) 2, the next generation of its single-use bronchoscope portfolio. The upgraded BFlex 2 series features four scope sizes and incorporates enhanced capabilities aimed at helping clinicians deliver improved care for both adult and pediatric patients across various hospital settings.

Therefore, driven by these advancements and growing clinical adoption, the bronchoscopes segment is anticipated to experience significant growth, thereby contributing substantially to the overall expansion of the disposable endoscopes market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall disposable endoscopes market:

North America is expected to lead the global disposable endoscopes market in 2024, driven by several key factors, including the rising incidence of healthcare-associated infections (HAIs), the growing prevalence of chronic conditions such as urological and gastrointestinal disorders, and continued advancements in healthcare technology.

One of the primary drivers in the region is the increasing risk of cross-contamination associated with reusable endoscopes. According to data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 31 hospital patients in the United States acquires at least one healthcare-associated infection. Similarly, recent data from the Provincial Infection Control Network of British Columbia (2025) reported that in Canada, 1 in 9 hospital patients contract an HAI, with over 220,000 such cases occurring annually. These statistics underscore the growing threat of infection in clinical settings, especially where reusable devices are used. Disposable endoscopes, being sterile and single-use, eliminate the risk of cross-contamination and are increasingly preferred in high-risk environments such as ICUs and emergency departments.

Additionally, technological innovations and regulatory support are strengthening the regional market. North America has witnessed a surge in product development and regulatory approvals, supported by a well-established healthcare infrastructure and the strong presence of key medical device companies. These conditions create a favorable ecosystem for market expansion.

For example, in May 2024, Olympus Corporation announced the launch of the DVM-B2 Digital Video Monitor, an integrated video processor and monitor specifically designed for use with single-use endoscopes. This system supports applications in bronchoscopy and ENT procedures and is compatible with Olympus's H-SteriScope(TM) Single-use Flexible Bronchoscopes and E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes. The device, manufactured by Hunan Vathin Medical Instruments Co., Ltd., is distributed exclusively by Olympus America, Inc., further reinforcing the company's commitment to advancing disposable endoscopy solutions in the region.

Moreover, increased awareness of infection control, favorable reimbursement frameworks, and ongoing partnerships and commercialization strategies among major industry players are expected to accelerate market growth further.

In conclusion, the convergence of rising HAI rates, technological innovation, growing demand for safer diagnostic tools, and strong regional healthcare investment is expected to make North America a dominant force in the disposable endoscopes market during the forecast period from 2025 to 2032.

Disposable Endoscopes Market key players:

Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

Recent Developmental Activities in the Disposable Endoscopes Market:

In September 2023, Olympus Corporation launched the Vathin E-SteriScope single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.
In April 2023, Verathon, a global leader in airway management solutions, unveiled the GlideScope(R) Spectrum(TM) QC featuring QuickConnect(TM) technology. This extensive lineup of single-use video laryngoscopes showcases a magnetic connector coupled with improvements in image quality, designed to support rapid and effective airway management.
In November 2022, PROACT Medical launched a new range of gas sampling lines along with their new line of single-use laryngoscopes to improve patient care in the European market.

Key takeaways from the disposable endoscopes market report study:

Market size analysis for current disposable endoscopes market size (2024), and market forecast over 8 years (2025 to 2032)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the disposable endoscopes market
Various opportunities available for the other competitors in the disposable endoscopes market space
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current disposable endoscopes market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the disposable endoscopes market growth in the future?

Target audience who can benefit from this disposable endoscopes market report study:

Disposable endoscopes product providers
Research organizations and consulting companies
Disposable endoscopes-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in disposable endoscopes
Various end-users who want to know more about the disposable endoscopes market and the latest developments in the disposable endoscopes market

Frequently Asked Questions for the Disposable Endoscopes Market:

1. What are disposable endoscopes?

The disposable endoscopes, also known as single-use endoscopes, are medical devices designed to perform minimally invasive diagnostic and therapeutic procedures within the body. Unlike reusable endoscopes, they are discarded after a single use, eliminating the need for sterilization and reprocessing.

2. What is the market for disposable endoscopes?

The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032.

3. What are the drivers for the disposable endoscopes market?

The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

4. Who are the key players operating in the disposable endoscopes market?

Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

5. Which region has the highest share in the disposable endoscopes market?

Among all the regions, North America is expected to dominate the disposable endoscopes market in the year 2024. This can be attributed to several factors, such as rising instances of cross-contamination and chronic conditions such as urological and gastrointestinal disorders. Additionally, the enhanced technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments are other major factors that are expected to drive the market for disposable endoscopes during the forecast period from 2025 to 2032.

1. Disposable Endoscopes Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Disposable Endoscopes Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Disposable Endoscopes Market Key Factors Analysis

5.1. Disposable Endoscopes Market Drivers
- 5.1.1. Increasing instances of cross-contamination and infections
- 5.1.2. Increasing instances of chronic conditions
- 5.1.3. Rising product development activities globally
5.2. Disposable Endoscopes Market Restraints and Challenges
- 5.2.1. Raising concerns about the environmental impact
- 5.2.2. Limitations associated with devices
- 5.2.3. Stringent regulations for some of the single-use endoscopes
5.3. Disposable Endoscopes Market Opportunities
- 5.3.1. Integration with imaging and navigation technologies

6. Disposable Endoscopes Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Disposable Endoscopes Market Assessment

7.1. By Product
- 7.1.1. Bronchoscopes
- 7.1.2. Gastroscopes
- 7.1.3. Dudenoscopes
- 7.1.4. Laryngoscopes
- 7.1.5. Others
7.2. By Application
- 7.2.1. Pulmonology
- 7.2.2. Gastroenterology
- 7.2.3. Urology
- 7.2.4. ENT
- 7.2.5. Others
7.3. By End-User
- 7.3.1. Hospitals & Clinics
- 7.3.2. Ambulatory Surgical Centers
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.1.2. Canada Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.1.3. Mexico Disposable Endoscopes Market Size in USD million (2022-2033)
- 7.4.2. Europe
  - 7.4.2.1. France Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.2.2. Germany Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.2.3. United Kingdom Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.2.4. Italy Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.2.5. Spain Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.2.6. Rest of Europe Disposable Endoscopes Market Size in USD million (2022-2033)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.3.2. Japan Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.3.3. India Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.3.4. Australia Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.3.5. South Korea Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.3.6. Rest of Asia-Pacific Disposable Endoscopes Market Size in USD million (2022-2033)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.4.2. Africa Disposable Endoscopes Market Size in USD million (2022-2033)
  - 7.4.4.3. South America Disposable Endoscopes Market Size in USD million (2022-2033)

8. Disposable Endoscopes Market Company and Product Profiles

8.1. Olympus Corporation
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Boston Scientific Corporation
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Ambu Inc.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. ProSurg Inc.
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Baxter
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Teleflex Incorporated
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Flexicare Medical Limited
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. AUG Medical
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. NeoScope Inc
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Xenocor Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. 3NT Medical
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Corinth MedTech, Inc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. PENTAX Medical
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Daichuan medical
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Omnivision
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Verathon
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy